Positive PD-L1 Expression Predicts Worse Outcome in Cutaneous Angiosarcoma.

about

Cutaneous angiosarcoma: update on biology and latest treatment.Association Between Programmed Death-Ligand 1 Expression and the Vascular Endothelial Growth Factor Pathway in Angiosarcoma.

P2860

Q47807442-51D49803-F5C8-4E98-9371-564533C0AE09 Q52721217-89C4942E-D69C-4620-9705-7CC32D60722F

P2860

Positive PD-L1 Expression Predicts Worse Outcome in Cutaneous Angiosarcoma.

Item

http://www.wikidata.org/entity/Q38613118

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Positive PD-L1 Expression Predicts Worse Outcome in Cutaneous Angiosarcoma.

@en

type

Item

label

Positive PD-L1 Expression Predicts Worse Outcome in Cutaneous Angiosarcoma.

@en

prefLabel

Positive PD-L1 Expression Predicts Worse Outcome in Cutaneous Angiosarcoma.

@en

P1476

Positive PD-L1 Expression Predicts Worse Outcome in Cutaneous Angiosarcoma.

@en

P2093

Akira Shimizu

http://www.w3.org/2001/XMLSchema#string

Daisuke Utsumi

http://www.w3.org/2001/XMLSchema#string

Kenzo Takahashi

http://www.w3.org/2001/XMLSchema#string

Kyoichi Kaira

http://www.w3.org/2001/XMLSchema#string

Masahiko Nishiyama

http://www.w3.org/2001/XMLSchema#string

Masahito Yasuda

http://www.w3.org/2001/XMLSchema#string

Osamu Ishikawa

http://www.w3.org/2001/XMLSchema#string

Takayuki Asao

http://www.w3.org/2001/XMLSchema#string

Yuko Okubo

http://www.w3.org/2001/XMLSchema#string

P2860

Nivolumab plus ipilimumab in advanced melanoma.

Anti-programmed cell death protein-1/ligand-1 therapy in different cancers

PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.

Programmed cell death ligand 1 expression in osteosarcoma.

Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp.

Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

P304

360-369

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JGO.2016.005843

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28831444

http://www.w3.org/2001/XMLSchema#string

P932

5560454

http://www.w3.org/2001/XMLSchema#string

Positive PD-L1 Expression Predicts Worse Outcome in Cutaneous Angiosarcoma.

about

P2860

P2860

Positive PD-L1 Expression Predicts Worse Outcome in Cutaneous Angiosarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932